Morning Briefing
Summaries of health policy coverage from major news organizations
Quality Issue Roundup: J & J Revamping Controls; The Odds For Orthopedic Surgery; Automatic Prescription Refills And Patient Compliance
The New York Times reports that Johnson & Johnson has said it will "revamp its quality controls, creating a single framework for its drug, medical device and consumer health care divisions."
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
